Cargando…
Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability
BACKGROUND: Nanofat was introduced by Tonnard and Verpaele in 2013. Their initial observations in intradermal applications showed improvement in the appearance of the skin. Since then, a number of Nanofat devices have been introduced. The cellular content in the processing of Nanofat is not the same...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780476/ https://www.ncbi.nlm.nih.gov/pubmed/33791619 http://dx.doi.org/10.1093/asjof/ojz028 |
_version_ | 1783631511373742080 |
---|---|
author | Cohen, Steven R Tiryaki, Tunç Womack, Hayley A Canikyan, Serli Schlaudraff, Kai Uwe Scheflan, Michael |
author_facet | Cohen, Steven R Tiryaki, Tunç Womack, Hayley A Canikyan, Serli Schlaudraff, Kai Uwe Scheflan, Michael |
author_sort | Cohen, Steven R |
collection | PubMed |
description | BACKGROUND: Nanofat was introduced by Tonnard and Verpaele in 2013. Their initial observations in intradermal applications showed improvement in the appearance of the skin. Since then, a number of Nanofat devices have been introduced. The cellular content in the processing of Nanofat is not the same in every device, yet the cellular composition is responsible for the biologic action of Nanofat. The authors sought to find a different means to produce a matrix rich Nanofat to optimize the cellular content. OBJECTIVES: The primary objective of this study was to compare cell counts, cultures, and cell viabilities produced by LipocubeNano (Lipocube, Inc., London, UK) in comparison to Tulip’s NanoTransfer (Tulip Medical, San Diego, CA) processing methods. METHODS: Twenty milliliters of fat were harvested from 10 patients in order to test two methods of Nanofat production. Ten milliliters of fat were used to assess each method and, after the final product was obtained, enzymatic digestion for stromal vascular fraction (SVF) isolation was performed. A Muse Flow-cytometer was used to measure cell counts and cell viabilities, cell cultures were performed, and cell images were taken with a florescent microscope. RESULTS: The LipocubeNano was shown to be superior to Tulip’s NanoTransfer system of progressive downsizing with final filtering, which appeared to trap more fibrous tissue leading to lower amounts of SVF. LipocubeNano resulted in higher cell counts (2.24 × 10(6)/cc), whereas Tulip’s NanoTransfer method resulted in a lower cell count at 1.44 × 10(6)/cc. Cell viability was the same (96.05%) in both groups. CONCLUSIONS: Nanofat from LipocubeNano has a higher regenerative cell count and more SVF cells than the other common mechanical method of Nanofat processing. This new means of mechanical processing preserves more matrix, optimizing the cellular content of the Nanofat, thus having potentially a higher regenerative effect. LEVEL OF EVIDENCE: 5: [Image: see text] |
format | Online Article Text |
id | pubmed-7780476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77804762021-03-30 Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability Cohen, Steven R Tiryaki, Tunç Womack, Hayley A Canikyan, Serli Schlaudraff, Kai Uwe Scheflan, Michael Aesthet Surg J Open Forum Research BACKGROUND: Nanofat was introduced by Tonnard and Verpaele in 2013. Their initial observations in intradermal applications showed improvement in the appearance of the skin. Since then, a number of Nanofat devices have been introduced. The cellular content in the processing of Nanofat is not the same in every device, yet the cellular composition is responsible for the biologic action of Nanofat. The authors sought to find a different means to produce a matrix rich Nanofat to optimize the cellular content. OBJECTIVES: The primary objective of this study was to compare cell counts, cultures, and cell viabilities produced by LipocubeNano (Lipocube, Inc., London, UK) in comparison to Tulip’s NanoTransfer (Tulip Medical, San Diego, CA) processing methods. METHODS: Twenty milliliters of fat were harvested from 10 patients in order to test two methods of Nanofat production. Ten milliliters of fat were used to assess each method and, after the final product was obtained, enzymatic digestion for stromal vascular fraction (SVF) isolation was performed. A Muse Flow-cytometer was used to measure cell counts and cell viabilities, cell cultures were performed, and cell images were taken with a florescent microscope. RESULTS: The LipocubeNano was shown to be superior to Tulip’s NanoTransfer system of progressive downsizing with final filtering, which appeared to trap more fibrous tissue leading to lower amounts of SVF. LipocubeNano resulted in higher cell counts (2.24 × 10(6)/cc), whereas Tulip’s NanoTransfer method resulted in a lower cell count at 1.44 × 10(6)/cc. Cell viability was the same (96.05%) in both groups. CONCLUSIONS: Nanofat from LipocubeNano has a higher regenerative cell count and more SVF cells than the other common mechanical method of Nanofat processing. This new means of mechanical processing preserves more matrix, optimizing the cellular content of the Nanofat, thus having potentially a higher regenerative effect. LEVEL OF EVIDENCE: 5: [Image: see text] Oxford University Press 2019-09-29 /pmc/articles/PMC7780476/ /pubmed/33791619 http://dx.doi.org/10.1093/asjof/ojz028 Text en © 2019 The American Society for Aesthetic Plastic Surgery, Inc. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Cohen, Steven R Tiryaki, Tunç Womack, Hayley A Canikyan, Serli Schlaudraff, Kai Uwe Scheflan, Michael Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability |
title | Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability |
title_full | Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability |
title_fullStr | Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability |
title_full_unstemmed | Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability |
title_short | Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability |
title_sort | cellular optimization of nanofat: comparison of two nanofat processing devices in terms of cell count and viability |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780476/ https://www.ncbi.nlm.nih.gov/pubmed/33791619 http://dx.doi.org/10.1093/asjof/ojz028 |
work_keys_str_mv | AT cohenstevenr cellularoptimizationofnanofatcomparisonoftwonanofatprocessingdevicesintermsofcellcountandviability AT tiryakitunc cellularoptimizationofnanofatcomparisonoftwonanofatprocessingdevicesintermsofcellcountandviability AT womackhayleya cellularoptimizationofnanofatcomparisonoftwonanofatprocessingdevicesintermsofcellcountandviability AT canikyanserli cellularoptimizationofnanofatcomparisonoftwonanofatprocessingdevicesintermsofcellcountandviability AT schlaudraffkaiuwe cellularoptimizationofnanofatcomparisonoftwonanofatprocessingdevicesintermsofcellcountandviability AT scheflanmichael cellularoptimizationofnanofatcomparisonoftwonanofatprocessingdevicesintermsofcellcountandviability |